IgM in the regulation of TB immunity
IgM 在结核免疫调节中的作用
基本信息
- 批准号:10551315
- 负责人:
- 金额:$ 73.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAlveolar MacrophagesAnimalsAntibodiesAntigensAntitubercular AgentsB-LymphocytesBacillusBacteriaBloodBone MarrowBronchoalveolar Lavage FluidCD4 Positive T LymphocytesCarbohydratesCell physiologyCellsCharacteristicsChimera organismChronicChronic PhaseCirculationCommunicable DiseasesContainmentDataDefectDendritic CellsDevelopmentDiseaseDisease OutcomeEvaluationExhibitsExperimental DesignsFutureGoalsGranulomaGranulomatousHelper-Inducer T-LymphocyteHistologicHumanHumoral ImmunitiesImmuneImmune SeraImmune responseImmunityImmunoglobulin GImmunoglobulin IsotypesImmunoglobulinsImmunologic FactorsImpairmentInfectionInflammationInterventionInvestigationIrrigationKnockout MiceLearningLiquid substanceLungMacacaMacrophageMediatingMicrobeModelingMonkeysMouse StrainsMusMycobacterium tuberculosisMycobacterium tuberculosis antigensNatural ResistanceOutcomePathogenesisPhasePhenotypePlasma CellsPlasmablastPlayPredispositionPublicationsReactionRegulationReportingResearch ProposalsRoleSerumShapesStructure of germinal center of lymph nodeSystemT-LymphocyteTestingTh1 CellsThymus GlandTissuesTuberculosisVaccinesWild Type MouseWorkacute infectionadaptive immunityantimicrobialchronic infectiondesigndifferential expressionexperimental studyimmunoregulationin vivoinsightmortalitymouse modelnonhuman primatenovelpathogenprogrammed cell death protein 1protective effectresponsetuberculosis immunity
项目摘要
Abstract
A role for T cells in the control of Mycobacterium tuberculosis (Mtb) is well established, that for B cells and
humoral immunity, however, is less well understood. Emerging evidence indicate B cells and immunoglobulins
(Igs) can modulate the immune response to Mtb in hosts such as humans, non-human primates (NHP), and
mice. In humans, antibodies (Ab) has been shown to modulate disease outcome and/or confer protection. We
have shown that S-/- mice, which lack secreted IgM, are more susceptible to Mtb compared to wild-type (WT)
C57BL/6. The susceptibility phenotype manifests as enhanced mortality and tissue bacterial loads in the
chronic phase of infection. S-/- mice also exhibit germinal center (GC) defects characterized by histological
abnormality, decreased levels of plasma cells/plasmablasts, and an impaired GC B cell and antigen (Ag)-
specific IgG response beginning in the acute phase of infection. The hypersusceptibility and GC-related
phenotypes can be ameliorated by therapy with immune serum procured from Mtb-infected WT mice. We have
observed enhanced Mtb susceptibility in two knockout mouse strains defective in GC B cells and follicular
helper T cells (Tfh), two major cellular components of GC, supporting a role for GC in defense against Mtb.
The S-/- data thus suggest that in the acute phase of infection, IgM plays an important role in the
development of an optimal GC reaction that is required, at least in part, for establishing effective adaptive
immunity for the control of chronic TB. We recently observed that the levels of lung CD4+ T cells and Th1 cells
are increased in the hypersusceptible S-/- mice relative to WT animals during infection. As functionally
distinct Th1 subsets (defined by differential expression of PD1 and KLRG1) that can be protective or
detrimental to a tuberculous host have recently been described, the seemingly paradoxical S-/- T cell
phenotype warrants further characterization, particularly in the context of the newly described Th1 subsets. IgM
can mediate antimicrobial activities by modulating opsonization, dendritic cell functions, T cell immunity and
humoral responses. Both natural and immune IgMs play a protective role against a variety of pathogens
including intracellular bacteria. Of note, we have detected Mtb Ag-specific IgM in the circulation of both naϊve
and infected mice and macaques. Mtb-specific IgM is also present in brochoalveolar lavage fluids (BALF) of
uninfected and infected monkeys, suggesting that natural and immune IgM may both play a role in regulating
anti-TB immunity, possible beginning in the early innate phase of Mtb-host interaction. Based on the above, we
posit that: (i) IgM plays a role in optimizing the immune response to Mtb, possibly at the very early phase of
infection in the lungs; (ii) IgM is required for establishing an optimal GC reaction that is required for the
development of effective adaptive immunity for the control of chronic TB; (iii) natural IgM may play an important
role in modulating the host response to Mtb. This proposal will rigorously test these hypotheses using both
mouse and monkey TB models. We will use a variety of genetically altered mouse strains which lack specific Ig
isotypes, together with bone marrow chimeras, serum therapy, and IgM-coated Mtb to probe the significance of
natural and immune IgM in regulating TB immunity. We will also use an ex vivo macaque infection model that
enables the evaluation of the effect of IgM on the interaction of Mtb with NHP alveolar macrophages. We
believe the combined mouse and monkey approach will shed light on the role of IgM in defense against Mtb,
provide mechanistic insights into how this Ab isotype regulates anti-tuberculous responses, and yield
information to guide future work on the humoral immunity and natural resistance in TB and the design of novel
interventions against the tubercle bacillus, including vaccines.
抽象的
T 细胞在控制结核分枝杆菌 (Mtb) 中的作用已得到充分证实,而 B 细胞和
然而,对体液免疫的了解还不太清楚。新证据表明 B 细胞和免疫球蛋白
(Igs) 可以调节人类、非人灵长类动物 (NHP) 等宿主对 Mtb 的免疫反应,
老鼠。在人类中,抗体 (Ab) 已被证明可以调节疾病结果和/或提供保护。我们
研究表明,与野生型 (WT) 相比,缺乏分泌型 IgM 的 S-/- 小鼠对 Mtb 更敏感
C57BL/6。易感性表型表现为死亡率和组织细菌负荷的增加
感染的慢性期。 S-/- 小鼠还表现出以组织学特征为特征的生发中心(GC)缺陷
异常、浆细胞/浆母细胞水平降低以及 GC B 细胞和抗原 (Ag) 受损 -
特异性 IgG 反应在感染急性期开始。高敏感性与GC相关
使用从 Mtb 感染的 WT 小鼠中获得的免疫血清进行治疗可以改善表型。我们有
观察到 GC B 细胞和滤泡缺陷的两种基因敲除小鼠品系的 Mtb 易感性增强
辅助 T 细胞 (Tfh) 是 GC 的两个主要细胞成分,支持 GC 在防御 Mtb 中发挥作用。
因此,S-/- 数据表明,在感染急性期,IgM 在感染过程中发挥着重要作用。
开发最佳的 GC 反应,至少部分地需要建立有效的适应性
免疫控制慢性结核病。我们最近观察到肺 CD4+ T 细胞和 Th1 细胞的水平
在感染过程中,与 WT 动物相比,高度敏感的 S-/- 小鼠中的表达增加。从功能上来说
不同的 Th1 子集(由 PD1 和 KLRG1 的差异表达定义)可以具有保护性或
最近描述了对结核宿主有害的现象,看似矛盾的S-/- T 细胞
表型需要进一步表征,特别是在新描述的 Th1 亚群的背景下。免疫球蛋白M
可通过调节调理作用、树突状细胞功能、T 细胞免疫和
体液反应。天然 IgM 和免疫 IgM 均对多种病原体发挥保护作用
包括细胞内细菌。值得注意的是,我们在两种幼稚小鼠的循环中都检测到了 Mtb Ag 特异性 IgM。
以及受感染的老鼠和猕猴。 Mtb 特异性 IgM 也存在于支气管肺泡灌洗液 (BALF) 中
未感染和感染的猴子,表明天然 IgM 和免疫 IgM 可能都在调节中发挥作用
抗结核免疫,可能始于结核分枝杆菌与宿主相互作用的早期先天阶段。基于以上情况,我们
假设: (i) IgM 在优化针对 Mtb 的免疫反应中发挥着作用,可能是在 Mtb 的早期阶段
肺部感染; (ii) IgM 是建立最佳 GC 反应所必需的,该反应是
发展有效的适应性免疫来控制慢性结核病; (iii) 天然 IgM 可能发挥重要作用
调节宿主对 Mtb 的反应。该提案将使用以下两种方法严格检验这些假设
小鼠和猴结核病模型。我们将使用多种缺乏特定 Ig 的转基因小鼠品系
同种型,连同骨髓嵌合体、血清疗法和 IgM 包被的 Mtb 来探讨
天然和免疫 IgM 调节结核免疫。我们还将使用离体猕猴感染模型
能够评估 IgM 对 Mtb 与 NHP 肺泡巨噬细胞相互作用的影响。我们
相信小鼠和猴子相结合的方法将阐明 IgM 在防御 Mtb 中的作用,
提供有关该抗体同种型如何调节抗结核反应的机制见解,并产生
指导结核病体液免疫和自然抵抗的未来工作以及新型药物设计的信息
针对结核杆菌的干预措施,包括疫苗。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John R. Chan其他文献
John R. Chan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John R. Chan', 18)}}的其他基金
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
Rv2623-Rv1747 相互作用:结核分枝杆菌体内命运的调节
- 批准号:
9973940 - 财政年份:2020
- 资助金额:
$ 73.63万 - 项目类别:
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
Rv2623-Rv1747 相互作用:结核分枝杆菌体内命运的调节
- 批准号:
10685658 - 财政年份:2020
- 资助金额:
$ 73.63万 - 项目类别:
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
Rv2623-Rv1747 相互作用:结核分枝杆菌体内命运的调节
- 批准号:
10553212 - 财政年份:2020
- 资助金额:
$ 73.63万 - 项目类别:
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
Rv2623-Rv1747 相互作用:结核分枝杆菌体内命运的调节
- 批准号:
10529446 - 财政年份:2020
- 资助金额:
$ 73.63万 - 项目类别:
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
结核病中吲哚胺 2,3-双加氧酶的免疫调节
- 批准号:
9921293 - 财政年份:2018
- 资助金额:
$ 73.63万 - 项目类别:
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
结核病中吲哚胺 2,3-双加氧酶的免疫调节
- 批准号:
10395488 - 财政年份:2018
- 资助金额:
$ 73.63万 - 项目类别:
Humoral immunity against the M. tuberculosis kasB persistent mutant
针对结核分枝杆菌 kasB 持久突变体的体液免疫
- 批准号:
9624948 - 财政年份:2018
- 资助金额:
$ 73.63万 - 项目类别:
相似海外基金
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
- 批准号:
23K08315 - 财政年份:2023
- 资助金额:
$ 73.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
- 批准号:
MR/X005046/1 - 财政年份:2023
- 资助金额:
$ 73.63万 - 项目类别:
Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
- 批准号:
23H03154 - 财政年份:2023
- 资助金额:
$ 73.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
- 批准号:
10607319 - 财政年份:2023
- 资助金额:
$ 73.63万 - 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
- 批准号:
471247 - 财政年份:2022
- 资助金额:
$ 73.63万 - 项目类别:
Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
- 批准号:
485971 - 财政年份:2022
- 资助金额:
$ 73.63万 - 项目类别:
Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
- 批准号:
22K06698 - 财政年份:2022
- 资助金额:
$ 73.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
- 批准号:
462596862 - 财政年份:2021
- 资助金额:
$ 73.63万 - 项目类别:
WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
- 批准号:
21K16251 - 财政年份:2021
- 资助金额:
$ 73.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
- 批准号:
NC/V001019/1 - 财政年份:2021
- 资助金额:
$ 73.63万 - 项目类别:
Research Grant